What is Late Breaking Clinical Trials?

Late Breaking Clinical Trials is an always-popular session where speakers present the results of a new research in heart failure. Featured on a plenary session stage, Late Breaking Clinical Trials provides exposure and recognition for major randomized trials and registries that will likely have a significant impact on clinical practice or result in significant advances in the field.

Clinical trials accepted for presentation will be: 

• Presented during the Late Breaking Clinical Trials session
• Accepted Late Breaking Clinical Trials abstracts will be published in an issue of the Journal of Cardiac Failure after the Annual Scientific Meeting. Authors will have the ability to update the submitted abstract prior to publication. JCF encourages all accepted Late Breaking Clinical Trials to submit full papers for further consideration

All late breaking data is embargoed until the day of Late Breaking Clinical Trials session.

If an accepted late breaking clinical trial abstract was submitted and accepted for general abstract/poster presentation at the HFSA Annual Scientific Meeting, it needs to be withdrawn by August 25, 2023.